Previous close | 1,409.00 |
Open | 1,394.23 |
Bid | 0.00 x N/A |
Ask | 1,400.00 x N/A |
Day's range | 1,394.23 - 1,394.23 |
52-week range | 855.89 - 1,416.90 |
Volume | |
Avg. volume | 359 |
Market cap | 2.05T |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | 63.84 |
EPS (TTM) | 21.84 |
Earnings date | 24 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Medtronic's (MDT) stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.
This medical device company is growing, but appears overvalued at the moment
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the second quarter on July 24 prior to the conference call.